Pfizer (Spain)
Impact in
-
- Schizophrenia research and treatment
-
- Rheumatoid Arthritis Research and Therapies
Papers in
- Urology 34
- Urinary Bladder and Prostate Research 33
- Top scholars
- Javier RejasCristina Varas‐LorenzoMiguel Ángel RuizVictoria BolósAntonio PardoJordi CastellsaguéLuis A. Garcı́a Rodrı́guezAntonio Martín
- Journals
- Value in Health (18 papers)European Psychiatry (13 papers)Annals of the Rheumatic Diseases (13 papers)Infectious Diseases and Therapy (10 papers)Vaccine (10 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Pfizer (Spain)
645 papers receiving 14.6k citations
Peers
Comparison fields: 5 of 183
- Psychiatry and Mental health 2.0k
- Rheumatology 1.8k
- Urology 460
- Pharmacology 1.2k
- Epidemiology 2.2k
Countries citing scholars working at Pfizer (Spain)
This map shows the geographic impact of research produced by authors working at Pfizer (Spain). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Pfizer (Spain) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pfizer (Spain) more than expected).
Fields of papers published by authors at Pfizer (Spain)
This network shows the impact of papers affiliated with Pfizer (Spain) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Pfizer (Spain) at the time of their publication.
About Pfizer (Spain)
In recent decades, authors affiliated with Pfizer (Spain) have published 790 papers, which have received a total of 18.4k indexed citations . Scholars at this organization have produced 21 papers in Geriatrics and Gerontology, 34 papers in Urology, 81 papers in Rheumatology, 75 papers in Psychiatry and Mental health and 17 papers in Internal Medicine on the topics of Health Systems, Economic Evaluations, Quality of Life (55 papers), Pneumonia and Respiratory Infections (39 papers), Atrial Fibrillation Management and Outcomes (34 papers), Urinary Bladder and Prostate Research (33 papers), Rheumatoid Arthritis Research and Therapies (30 papers), Schizophrenia research and treatment (29 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (28 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (27 papers). Their work is cited by papers focused on Psychiatry and Mental health (2.0k citations), Rheumatology (1.8k citations), Urology (460 citations), Pharmacology (1.2k citations) and Epidemiology (2.2k citations). Authors at Pfizer (Spain) collaborate with scholars in Spain, United States and United Kingdom and have published in prestigious journals including Value in Health, European Psychiatry, Annals of the Rheumatic Diseases, Infectious Diseases and Therapy and Vaccine. Some of Pfizer (Spain)'s most productive authors include Javier Rejas, Cristina Varas‐Lorenzo, Miguel Ángel Ruiz, Victoria Bolós, Antonio Pardo, Jordi Castellsagué, Luis A. Garcı́a Rodrı́guez, Antonio Martín, Jose L. Rivas and Julio Bobes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.